Generate:Biomedicines

For the second year in a row, Sean Martin, our Chief Legal Officer & General Counsel, has been named to the GC Magazine & GC Powerlist. Compiled by The Legal 500, this prestigious list recognizes the most influential and innovative in-house legal leaders across industries. Sean’s recognition highlights his pivotal role in securing key patents, navigating the evolving #AI regulatory landscape, and forging impactful collaborations with partners like Novartis and MD Anderson Cancer Center. His leadership ensures Generate remains at the forefront of AI-driven drug development while safeguarding our mission. Learn more about Sean's honor: https://lnkd.in/gCNc_wcX #AudaciouslyAmbitious | #RelentlesslyCurious

How is #AI reshaping biotech R&D? On December 3, our CTO and Co-Founder, Gevorg Grigoryan, joins Martin Stumpe of Danaher Corporation to discuss “Beyond the Hype: Advancements in Protein Modeling, Digital Pathology, and Human Virtual Models” at the 2024 Danaher Summit. Gevorg will share the stage with Mark DePristo, CEO of BigHat Biosciences; Emma Lundberg, Professor of Bioengineering and Pathology at Stanford University; and Faisal Mahmood, Associate Professor at Harvard Medical School, to explore how computational advances are transforming how medicines are designed and developed. Ready to help shape the future of R&D? Join #TeamGenerate as Head of Computational Protein Generation: https://lnkd.in/etwKgu7K #ProgrammingBiology | #GenerativeAI

In Citeline's latest podcast, senior writer Joseph Haas hosts our CFO Jason Silvers and Gerardo Ubaghs Carrión, CFO of Frontier Medicines. They dive into the recent trends in biopharma M&A and discuss what’s driving today’s deal landscape. Jason shared his perspective on opportunities ahead, saying, “As more data comes in and the regulatory landscape evolves, we’re likely to see renewed interest in quality assets that bring real value to patients.” Listen now to explore what’s next: ?https://lnkd.in/eDmvxx_r #Biotech | #GenerativeAI

Today, our CFO Jason Silvers joins a panel at Guggenheim Partners’ inaugural Healthcare Innovation Conference in Boston to discuss the breakthrough technologies driving biotech forward. In “Immunology & Inflammation: Cutting-Edge Technologies Driving the Next Wave of Biotech Breakthroughs,” Jason will share how our programs, including GB-0895 which is targeting TSLP for severe asthma, support our commitment to using generative biology to engineer better medicines for patients. Joining Jason on this panel are Iain McGill of Quell Therapeutics, Vishal Patel of Triveni Bio, and Jo Viney of Seismic Therapeutic, with moderators Yatin Suneja and Seamus Fernandez. Explore our work in immunology and inflammation here: https://lnkd.in/eEpPjrTF #GenerativeAI | #ProgrammingBiology

Automation is transforming pharmaceutical labs, with 47% of workers needing reskilling by 2025. Later today, at #FutureLabsWest by AMG World, our Ilja Kuesters from Assay Automation & Qualification, will host a roundtable titled, “Implementing Robots to Collaborate Seamlessly with Human Researchers: Enhancing Productivity and Bio Safety in Lab Environments.” Ilja will explore how robotics integration can elevate both productivity and biosafety standards in lab settings. Ready to see how labs are evolving to meet tomorrow’s demands? Find out more here: https://lnkd.in/ebnHsfBt #TeamGenerate | #UnapologeticallyScientific

In a rapidly evolving business world, collaboration between CEOs and HR leaders is critical.?Beth Anton Grous, our Chief People Officer, joins top leaders at SHRM’s CEO Academy in New York City to discuss why a strategic partnership between CEOs and HR leaders is essential to company success. On the panel, “The Power Duo: Why Every CEO Needs a Strategic HR Leader at Their Side,” Beth will be joined by John Ferguson, SHRM-CP, PHR, CHRO of NASCAR, and Michael Fraccaro, CPO of Mastercard, with Bob Rothman from Gap International moderating. Together, they’ll explore the impact of CEO-HR collaboration on culture, performance, and executive alignment. Don’t miss the chance to see what’s shaping the future of executive leadership: https://lnkd.in/e2a8vDjW #TeamGenerate | #RelentlesslyCurious

Congratulations to our co-founder, Molly Gibson, on being named one of “The Top 50 Biotech Entrepreneurs of 2024” by Great Entrepreneurs! This award honors leaders reshaping biotech through bold innovation and a commitment to advancing patient care. Molly’s visionary work continues to shape the future of generative biology. Want to see who else is leading the charge? Explore the full list: https://lnkd.in/gYvy9J6w #UnapologeticallyScientific | #RelentlesslyCurious

Our Head of Intellectual Property, K. Nicole Clouse, will speak at Harvard Law School's Artificial Intelligence and Intellectual Property Law Conference. Moderated by Matthew F. Ferraro from the U.S. Department of Homeland Security, the panel will feature Nicole alongside experts Jeff Behrends from Harvard University, John Palfrey from the MacArthur Foundation, Steve Satterfield from Meta and Erin B. Sheppard from Booz Allen Hamilton. In “What AI Can Do Today, and Where AI Is Headed,” they’ll explore AI’s role in reshaping IP law, from today’s applications to tomorrow’s possibilities, and the ethical responsibilities that come with it. Hear what’s next for AI and IP: https://lnkd.in/eT-T5DTf #GenerativeAI | #RelentlesslyCurious

In a recent STAT article, “7 Companies to Watch in AI Protein Design,” Brittany Trang highlights companies advancing therapeutic protein design with #AI, each addressing the field’s challenges in distinct ways. #TeamGenerate is excited to be part of this revolution in drug discovery, with an AI platform built for both optimization of existing proteins and de novo protein generation. The future of #ProteinDesign is here. Learn more: https://lnkd.in/er_54XzE #GenerativeAI | #ProgrammingBiology

In a new article for Nature Portfolio, journalist?Sara Reardon explores “Five structural-biology questions that still challenge AI,” along with a number of experts in the field including?John Ingraham, our Head of Machine Learning, Alena Khmelinskaia, David Baker (Institute for Protein Design, University of Washington), Jue Wang, Mohammed AlQuraishi, Debora Marks, Martin Steinegger, Kevin Yang, and Tanja Kortemme. Learn more about these exciting frontiers for the field, as well as how #TeamGenerate is combining experimental and computational approaches to drive progress: https://lnkd.in/e5CMRzGx #GenerativeAI | #ProgrammingBiology